Insider trades

Patel Anish, COO of Enliven Therapeutics ELVN, has filed 0 purchases and 45 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 02/12.

Patel Anish

COO
First filing
23/02/27
Trades
71 trades
Buys / sales
0 / 45
12-month net buying
−$1.7M
Last trade
02/12

Trading activity

Transactions

Trade type
ELVN
Open-market sale10b5-1 plan01/0901/1348,300 sh2 trades$27.98avg.$1,351,560.36−18.3%
ELVN
Open-market sale10b5-1 plan25/12/0825/12/106,663 sh2 trades$21.02avg.$140,062.98−2.5%
ELVN
Open-market sale10b5-1 plan25/11/0725/11/126,667 sh2 trades$17.40avg.$116,034.12−2.4%
Open-market sale10b5-1 plan25/10/0725/10/096,667 sh$20.10$134,006.7−2.4%
Open-market sale10b5-1 plan25/09/0825/09/106,667 sh$20.24$134,940.08−2.3%
ELVN
Open-market sale10b5-1 plan25/08/0725/08/116,667 sh2 trades$18.24avg.$121,635.05−2.2%
ELVN
Open-market sale10b5-1 plan25/07/0725/07/096,667 sh2 trades$19.79avg.$131,959.95−2.2%
ELVN
Open-market sale10b5-1 plan25/06/0925/06/116,667 sh2 trades$20.34avg.$135,589.91−2.2%
ELVN
Open-market sale10b5-1 plan25/05/0725/05/096,667 sh3 trades$18.39avg.$122,598.38−2.1%
ELVN
Open-market sale10b5-1 plan25/04/0725/04/096,667 sh3 trades$18.04avg.$120,281.59−2.1%
Open-market sale10b5-1 plan25/03/0725/03/116,667 sh$21.44$142,940.48−2.0%
Open-market sale25/02/0725/02/106,667 sh$21.93$146,207.31−2.0%
ELVN
Open-market sale10b5-1 plan25/01/0725/01/1028,367 sh4 trades$24.18avg.$685,825.49No record
Open-market sale10b5-1 plan24/10/1824/10/22716 sh$30.00$21,480−0.2%
ELVN
Open-market sale10b5-1 plan24/07/12–24/07/1624/07/1650,000 sh3 trades$25.06avg.$1,252,787.62−12.7%
Open-market sale10b5-1 plan24/06/0624/06/101,133 sh$20.06$22,727.98−100.0%
Open-market sale10b5-1 plan24/05/1424/05/161,107 sh$25.00$27,675−100.0%
Open-market sale10b5-1 plan24/05/0924/05/13260 sh$25.06$6,515.6−100.0%
Open-market sale10b5-1 plan24/05/0624/05/084,875 sh$22.72$110,760−100.0%
Open-market sale10b5-1 plan24/04/1124/04/1517,500 sh$25.03$438,025−100.0%